Back to Agenda
R&D and Technology Outsourcing Today: An Industry Update
Session Chair(s)
Keith Wenzel
Volunteer
DIA Study Endpoints Community, United States
This session will explore the current trends in outsourcing from large strategic to functional sourcing to technology partnerships, as well as identify new trends and hear perspectives about the future of outsourcing.
Learning Objective : Discuss the most prevalent models today for R&D and associated technology outsourcing; Describe the resulting benefits and challenges for the various partnering models; Identify new trends in outsourcing and hear perspectives about the future of outsourcing.
Speaker(s)
CRO Perspective
Heather Zigmund, PharmD
AstraZeneca, United States
Senior Director, Global Head of Study Management Early Stage Development BioPhar
CMO Perspective
Esther Sadler-Williams, MPharm, MSc, RPh
Catalent Pharma Solutions, Inc., United Kingdom
Global Director, Strategic Development and Innovation
Pharmaceutical Perspective on Outsourcing Trends
Keith E. Anderson, PhD
Seragon Pharmaceuticals, United States
Vice President, Pharmaceutical Sciences
Have an account?